Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2025-06-13 00:00:00 ET · period of report 2025-06-12 · accession 0001415889-25-017325 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-13 | 2025-06-12 | ORIC | Piscitelli Dominic | CFO | S - Sale | $10.00 | -300 | 101.8K | -0.3% | -$3,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-12 | S | D | 300 | $10.00 | 101,817 | D | — | — |